FDA Drug Application (012813) for BLEPHAMIDE by ALLERGAN

Back to FDA Applications sponsored by ALLERGAN

Application Number012813
Product Number002
FormSUSPENSION;OPHTHALMIC
Dosage0.2%;10%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBLEPHAMIDE
Active IngredientPREDNISOLONE ACETATE; SULFACETAMIDE SODIUM



Back to FDA Applications sponsored by ALLERGAN

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.